Login / Signup

MiR-616-3p modulates cell proliferation and migration through targeting tissue factor pathway inhibitor 2 in preeclampsia.

Yetao XuDan WuZiyan JiangYuanyuan ZhangSailan WangZhonghua MaBingqing HuiJing WangWeiping QianZhiping GeLizhou Sun
Published in: Cell proliferation (2018)
Our results demonstrated that TFPI2 plays a vital role in the progression of PE and might provide a prospective therapeutic strategy to mitigate the severity of the disorder.
Keyphrases
  • single cell
  • early onset
  • cell therapy
  • cancer therapy
  • pregnant women
  • mesenchymal stem cells
  • bone marrow